NCT01193192

A Retrospective Analysis of Neevo® and NeevoDHA® Compared to a Standard Prenatal Vitamin in Anemia During Pregnancy

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 30 (actual)
• Sponsor: Pamlab, L.L.C. · Industry
• Sex: Female
• Age: 21 Years – 39 Years
• Healthy volunteers: Accepted

Summary

This study is a multi-site, retrospective chart review to determine the effect of Neevo® or NeevoDHA® (with higher folate and B12) versus standard prenatal vitamins on hemoglobin (Hgb) levels in pregnant women throughout the course of pregnancy. Neevo® is a prescription medical food indicated for the dietary management of women under a doctor's care who face high risk pregnancies, older overactive bladder (OB) patients and patients unable to fully metabolize folic acid. Data will be collected from existing patient charts of subjects administered Neevo® or NeevoDHA® daily compared to subjects administered a prenatal vitamin daily.

Conditions

• Anemia in Pregnancy
• Pre-eclampsia

Interventions

Type	Name	Description
OTHER	Neevo®	A prenatal "medical food" - analogous to a prenatal vitamin but containing L-methylfolate in addition to folic acid
OTHER	Prenatal vitamins	for inclusion in the Control Group, prenatal vitamins must have contained ≤1mg folic acid, 27 - 35mg iron, and ≤12mcg vitamin B12.

Timeline

• Start date: 2010-07-01
• Primary completion: 2010-11-01
• Completion: 2010-11-01
• First posted: 2010-09-01
• Last updated: 2011-11-23

Locations

3 sites across 1 country: United States